2009
DOI: 10.1038/ijir.2008.67
|View full text |Cite
|
Sign up to set email alerts
|

‘Up and coming’ treatments for premature ejaculation: progress towards an approved therapy

Abstract: It is generally accepted that premature ejaculation (PE) is a more common problem than erectile dysfunction, although at present the options currently available for the treatment of PE are limited to behavioural psychotherapy and 'off-label' prescribing of pharmacological therapies. A sexual complaint with such a high prevalence together with an increasing understanding of the psychosocial consequences of PE has naturally stimulated the interest of the pharmaceutical industry and the first products designed sp… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
10
0
1

Year Published

2009
2009
2016
2016

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 11 publications
(11 citation statements)
references
References 83 publications
0
10
0
1
Order By: Relevance
“…Increased IELT and improvements in distress and interpersonal difficulty have been reported following such treatment 55,58,61 . The opioid receptor agonist, tramadol, has also been evaluated as on-demand treatment for PE and was shown to prolong IELT compared with placebo 64 ; however, concern about the risk of abuse and dependence with an opioid drug may limit the use of tramadol 60 . The PDE-5 inhibitors do not prolong IELT in men with PE, but limited data suggest a possible role for the combination of a PDE-5 inhibitor and an SSRI in men with ED and comorbid PE 59,60 .…”
Section: Pharmacotherapymentioning
confidence: 99%
“…Increased IELT and improvements in distress and interpersonal difficulty have been reported following such treatment 55,58,61 . The opioid receptor agonist, tramadol, has also been evaluated as on-demand treatment for PE and was shown to prolong IELT compared with placebo 64 ; however, concern about the risk of abuse and dependence with an opioid drug may limit the use of tramadol 60 . The PDE-5 inhibitors do not prolong IELT in men with PE, but limited data suggest a possible role for the combination of a PDE-5 inhibitor and an SSRI in men with ED and comorbid PE 59,60 .…”
Section: Pharmacotherapymentioning
confidence: 99%
“…This cream contains nine different compounds, some with local anesthetic and vasodilatatory properties. SS cream is available for use only in Korea and, to date, all the studies conducted on its efficacy were published by the same group and took place there [38].…”
Section: Ss Creammentioning
confidence: 99%
“…Nevertheless, it has been postulated that "on-demand" treatment of PE with conventional SSRIs would only be successful when combined with a 5-HT1 A receptor antagonist or some other treatment that would acutely stimulate serotonin release [38].…”
Section: Ssrismentioning
confidence: 99%
“…First, psychological interventions can help men develop sexual skills for delaying ejaculation by increasing their sexual confidence and diminishing their performance anxiety. Second, it can resolve psychological and interpersonal issues, which may have precipitated, maintained, or been consequences of PE symptoms for the man, his partner, or the couple [61516]. However, the outcomes in a majority of psychotherapy studies are not well controlled or randomized, and few of them meet the requirements of evidence-based studies.…”
Section: Behavioral Therapy and Psychotherapymentioning
confidence: 99%